Illinois 2025-2026 Regular Session

Illinois Senate Bill SB2259

Introduced
2/7/25  
Refer
2/7/25  
Refer
3/12/25  
Refer
4/11/25  

Caption

HEALTH CARE GENERATIVE AI USE

Summary

SB2259 amends the Illinois Medical Practice Act of 1987 to regulate the use of generative artificial intelligence in health care communications. The bill applies to health facilities, clinics, physician’s offices, and group practice offices that use generative AI to create written or verbal communications about a patient’s clinical information. It defines key terms such as artificial intelligence, generative artificial intelligence, health care provider, patient clinical information, clinic, health facility, physician’s office, and office of a group practice. The bill requires covered entities to ensure that AI-generated patient communications include specified safeguards, including a disclaimer telling the patient the communication was generated by generative AI. It also sets out that communications generated by AI but read and reviewed by a human licensed or certified health care provider are exempt from the new requirements. The bill further provides that violations by licensed health facilities or clinics would be penalized under rules adopted by the Department of Financial and Professional Regulation, while violations by physicians would be subject to penalties determined by the Illinois State Medical Board.

Impact

SB2259 would create a new section of the Medical Practice Act governing AI-assisted patient communications and would add compliance obligations for health care providers and facilities that use generative AI for clinical messaging. It would not regulate purely administrative communications such as scheduling or billing, but it would affect any written or verbal communication about a patient’s health status. The bill would also give state licensing and regulatory bodies authority to enforce violations through rulemaking and professional discipline, thereby expanding oversight of AI use in clinical settings.

Sentiment

Based on the bill text and available context, the measure appears to be a consumer-protection and transparency bill aimed at ensuring patients know when AI is being used in their care communications. There is no recorded committee testimony or vote history in the provided materials, so no formal support or opposition is documented here. The overall framing suggests a cautious, regulatory approach rather than a permissive one, with an emphasis on disclosure and human review.

Contention

The main point of potential contention is whether the bill’s disclosure and compliance requirements are sufficiently flexible for health systems that want to use generative AI to improve efficiency, versus whether they are necessary to protect patients from misleading or unreviewed AI-generated communications. Another likely issue is the scope of the exemption for communications reviewed by a human provider, including how much review is enough to remove the communication from the bill’s requirements. Enforcement authority may also be debated, particularly the division between DFPR rulemaking for facilities and Medical Board penalties for physicians.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.